Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Efficacy and Safety Study of Antileishmanial Drugs for Treatment of Visceral Leishmaniasis in Brazil

NCT01310738 is registered in ClinicalTrials.gov with University of Brasilia as lead sponsor.

NCT NCT01310738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Efficacy and Safety Study of Antileishmanial Drugs for Treatment of Visceral Leishmaniasis in Brazil
Lead sponsor
University of Brasilia
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2011
Completion date
February 28, 2015
Enrollment
378 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis